ARONORA, LLC

Company Information

Company Name
ARONORA, LLC
Address
3500 SW BRIDLEMILE LN
PORTLAND, OR, -
Phone
n/a
URL
n/a
DUNS
804889348
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,455,351.00
5
SBIR Phase II
$7,239,016.00
3

Award List

  1. Therapeutic thrombin analogs

    Amount: $1,771,244.00

    DESCRIPTION (provided by applicant): Stroke and heart attack are the leading causes of mortality and grave morbidity. The goal of this Fast-Track STTR grant application is to enable preclinical invest ...

    SBIR Phase II 2010 Department of Health and Human Services
  2. Therapeutic factor XI blockade for sepsis

    Amount: $297,486.00

    DESCRIPTION (provided by applicant): This Phase I SBIR grant will support the initial commercial development of a single dose injectable biological product candidate, recombinant humanized anti-factor ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Development of a Sequencing Batch Biofilm Reactor for Treatment of Pesticide Rinsewater

    Amount: $75,000.00

    NON-TECHNICAL SUMMARY: Pesticide formulation and agricultural-chemical facilities generate a dilute troublesome pesticide rinsewater that is difficult to dispose of due to its low volume, highly varia ...

    SBIR Phase I 2003 Department of Agriculture
  4. Therapeutic thrombin analogs

    Amount: $457,672.00

    DESCRIPTION (provided by applicant): Stroke and heart attack are the leading causes of mortality and grave morbidity. The goal of this Fast-Track STTR grant application is to enable preclinical invest ...

    SBIR Phase I 2009 Department of Health and Human Services
  5. Factor XI inhibitor for thrombosis

    Amount: $309,528.00

    DESCRIPTION (provided by applicant): Thrombotic cardiovascular diseases including venous thromboembolism, myocardial infarction, and ischemic stroke, remain leading causes of death and disability in t ...

    SBIR Phase I 2011 Department of Health and Human Services
  6. Therapeutic factor XI blockade for sepsis

    Amount: $2,957,729.00

    DESCRIPTION (provided by applicant): This SBIR Phase II grant will support the commercial development of an injectable biological product candidate, a unique proprietary recombinant humanized anti-fac ...

    SBIR Phase II 2012 Department of Health and Human Services
  7. Factor XI inhibitor for thrombosis

    Amount: $2,510,043.00

    DESCRIPTION (provided by applicant): Thrombotic cardiovascular diseases including venous thromboembolism (VTE), deep vein thrombosis (DVT), myocardial infarction, and ischemic stroke, remain leading c ...

    SBIR Phase II 2012 Department of Health and Human Services
  8. Factor XI Inhibition for the Treatment of Ischemic Stroke

    Amount: $315,665.00

    DESCRIPTION (provided by applicant): One of the underlying causes of acute ischemic stroke (AIS) is the thrombotic-thromboembolic occlusion of cerebral blood vessels. Early use of tissue-type plasmino ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government